CSPIA
GH icon

Cary Street Partners Investment Advisory’s Guardant Health GH Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5
Closed -$148 – 1076
2023
Q3 		$148 Buy
+5
New +$176 ﹤0.01% 1837

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Cary Street Partners Investment Advisory's GH Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Guardant Health (GH) in Q4 2023, closing a stake of 5 shares — an estimated $148 sold.

Cary Street Partners Investment Advisory first reported a position in GH in Q3 2023 and held it in 1 quarter. The position peaked at $148 in Q3 2023. 295 funds tracked by Wall St. Rank hold GH as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 5 Guardant Health shares in Q4 2023, an estimated $148.
  • Cary Street Partners Investment Advisory first reported a position in Guardant Health in Q3 2023 and held it in 1 quarter.
  • Cary Street Partners Investment Advisory's Guardant Health position peaked at $148 in Q3 2023.
  • 295 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.